New study aims to catch heart risks early in cancer treatment
NCT ID NCT07058454
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 5,000 cancer patients receiving chemotherapy or targeted drugs to watch for heart-related side effects. Researchers use regular heart tests and blood markers to detect problems early. The goal is to create a system that predicts and prevents serious heart events, while also tracking how these side effects affect patients' quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sixth Affiliated Hospital, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 5106555, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?